Breaking News Instant updates and real-time market news.

LSPD

Lightspeed

$56.76 /

+4.32 (+8.24%)

11:00
12/02/20
12/02
11:00
12/02/20
11:00

Lightspeed price target raised to C$80 from C$67 at CIBC

CIBC analyst Todd Coupland raised the firm's price target on Lightspeed to C$80 from C$67 and keeps an Outperformer rating on the shares.

  • 11

    Sep

LSPD Lightspeed
$56.76 /

+4.32 (+8.24%)

12/02/20 Scotiabank
Lightspeed price target raised to C$70 from C$56 at Scotiabank
11/29/20 BTIG
Lightspeed downgraded to Neutral from Buy at BTIG
11/09/20 RBC Capital
Lightspeed price target raised to $56 from $47 at RBC Capital
11/06/20 CIBC
Lightspeed price target raised to C$67 from C$50 at CIBC

TODAY'S FREE FLY STORIES

Hot Stocks
Total to acquire 20% interest in Adani Green Energy from Adani Group » 06:32
01/19/21
01/19
06:32
01/19/21
06:32
TOT

Total

$37.00 /

+19 (+4.00%)

Total announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOT Total
$37.00 /

+19 (+4.00%)

TOT Total
$37.00 /

+19 (+4.00%)

01/15/21 JPMorgan
Total price target raised to EUR 46 from EUR 44 at JPMorgan
01/14/21 Societe Generale
Societe Generale downgrades three EU oil & gas names after strong performances
01/13/21 Credit Suisse
Total price target raised to EUR 41.50 from EUR 39 at Credit Suisse
01/11/21 Mizuho
Total initiated with a Neutral at Mizuho
TOT Total
$37.00 /

+19 (+4.00%)

Downgrade
ViacomCBS downgraded to Underweight from Overweight at Barclays » 06:30
01/19/21
01/19
06:30
01/19/21
06:30
VIAC

ViacomCBS

$45.29 /

-0.71 (-1.54%)

Barclays analyst Kannan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIAC ViacomCBS
$45.29 /

-0.71 (-1.54%)

VIAC ViacomCBS
$45.29 /

-0.71 (-1.54%)

01/15/21 MoffettNathanson
ViacomCBS price target raised to $50 from $26 at MoffettNathanson
01/12/21 Wells Fargo
ViacomCBS price target raised to $43 from $30 at Wells Fargo
01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
01/05/21 Goldman Sachs
ViacomCBS price target raised to $40 from $37 at Goldman Sachs
VIAC ViacomCBS
$45.29 /

-0.71 (-1.54%)

VIAC ViacomCBS
$45.29 /

-0.71 (-1.54%)

VIAC ViacomCBS
$45.29 /

-0.71 (-1.54%)

VIAC ViacomCBS
$45.29 /

-0.71 (-1.54%)

Periodicals
TSMC, UMC to see full capacity utilization for 28nm through Q3, DigiTimes says » 06:29
01/19/21
01/19
06:29
01/19/21
06:29
TSM

TSMC

$125.26 /

-1.04 (-0.82%)

, UMC

UMC

$8.79 /

-0.715 (-7.52%)

Both TSMC (TSM) and UMC…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSM TSMC
$125.26 /

-1.04 (-0.82%)

UMC UMC
$8.79 /

-0.715 (-7.52%)

TSM TSMC
$125.26 /

-1.04 (-0.82%)

01/14/21 Needham
Intel upgraded to Buy from Hold at Needham
01/12/21
Fly Intel: Top five analyst upgrades
01/12/21 Bernstein
TSMC upgraded to Outperform from Market Perform at Bernstein
12/29/20 RBC Capital
Intel intraday move on Third Point news looks 'overdone,' says RBC Capital
UMC UMC
$8.79 /

-0.715 (-7.52%)

10/12/20 Credit Suisse
UMC upgraded to Outperform from Neutral at Credit Suisse
09/14/20 HSBC
UMC upgraded to Buy from Hold at HSBC
09/09/20 JPMorgan
UMC upgraded to Neutral from Underweight at JPMorgan
08/02/20 Goldman Sachs
UMC upgraded to Buy from Neutral at Goldman Sachs
TSM TSMC
$125.26 /

-1.04 (-0.82%)

TSM TSMC
$125.26 /

-1.04 (-0.82%)

TSM TSMC
$125.26 /

-1.04 (-0.82%)

TSM TSMC
$125.26 /

-1.04 (-0.82%)

UMC UMC
$8.79 /

-0.715 (-7.52%)

Syndicate
ProPhase Labs 3M share Secondary priced at $12.50 » 06:28
01/19/21
01/19
06:28
01/19/21
06:28
PRPH

ProPhase Labs

$15.80 /

+0.35 (+2.27%)

ThinkEquity, a division…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRPH ProPhase Labs
$15.80 /

+0.35 (+2.27%)

PRPH ProPhase Labs
$15.80 /

+0.35 (+2.27%)

Syndicate
TCR2 Therapeutics files to sell $125M in common stock » 06:27
01/19/21
01/19
06:27
01/19/21
06:27
TCRR

TCR2 Therapeutics

$32.87 /

-0.93 (-2.75%)

Goldman Sachs & Co.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$32.87 /

-0.93 (-2.75%)

TCRR TCR2 Therapeutics
$32.87 /

-0.93 (-2.75%)

12/22/20 Mizuho
Autolus, Arcus among top 2021 oncology picks at Mizuho
12/15/20 Mizuho
TCR2 Therapeutics price target raised to $58 from $33 at Mizuho
12/14/20 Piper Sandler
TCR2 Therapeutics price target raised to $45 from $35 at Piper Sandler
12/14/20 BMO Capital
TCR2 Therapeutics price target raised to $65 from $46 at BMO Capital
TCRR TCR2 Therapeutics
$32.87 /

-0.93 (-2.75%)

  • 29
    Jul
Downgrade
Acadia Realty Trust downgraded to Neutral from Buy at BofA » 06:27
01/19/21
01/19
06:27
01/19/21
06:27
AKR

Acadia Realty Trust

$15.69 /

-0.07 (-0.44%)

BofA analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKR Acadia Realty Trust
$15.69 /

-0.07 (-0.44%)

06:10 Today BofA
Acadia Realty Trust downgraded to Neutral from Buy at BofA
01/13/21 Jefferies
Jefferies upgrades 'overlooked' Acadia Realty Trust to Buy
01/13/21 Jefferies
Acadia Realty Trust upgraded to Buy from Hold at Jefferies
12/30/20 Truist
Acadia Realty Trust price target raised to $15 from $12 at Truist
AKR Acadia Realty Trust
$15.69 /

-0.07 (-0.44%)

Upgrade
Alsea upgraded to Overweight from Equal Weight at Barclays » 06:27
01/19/21
01/19
06:27
01/19/21
06:27
ALSSF

Alsea

$0.00 /

+ (+0.00%)

Barclays analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ALSSF Alsea
$0.00 /

+ (+0.00%)

11/02/20 Scotiabank
Alsea downgraded to Sector Perform from Outperform at Scotiabank
09/09/20 BBVA
Alsea upgraded to Outperform from Underperform at BBVA
06/26/20 Morgan Stanley
Alsea upgraded to Overweight from Equal Weight at Morgan Stanley
Periodicals
Tesla asks NHTSA to declare display issue 'inconsequential,' Reuters reports » 06:25
01/19/21
01/19
06:25
01/19/21
06:25
TSLA

Tesla

$826.55 /

-17.94 (-2.12%)

Tesla on Friday filed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$826.55 /

-17.94 (-2.12%)

TSLA Tesla
$826.55 /

-17.94 (-2.12%)

01/15/21 Wedbush
Tesla price target raised to $950 from $715 at Wedbush
01/13/21
Fly Intel: Top five analyst initiations
01/13/21 Edward Jones
Edward Jones starts Tesla at Hold, sees leadership balanced by competition
01/13/21 Edward Jones
Tesla initiated with a Hold at Edward Jones
TSLA Tesla
$826.55 /

-17.94 (-2.12%)

  • 14
    Feb
TSLA Tesla
$826.55 /

-17.94 (-2.12%)

TSLA Tesla
$826.55 /

-17.94 (-2.12%)

TSLA Tesla
$826.55 /

-17.94 (-2.12%)

Recommendations
Turning Point Therapeutics price target raised to $190 from $130 at H.C. Wainwright » 06:25
01/19/21
01/19
06:25
01/19/21
06:25
TPTX

Turning Point Therapeutics

$131.57 /

-6.23 (-4.52%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$131.57 /

-6.23 (-4.52%)

TPTX Turning Point Therapeutics
$131.57 /

-6.23 (-4.52%)

01/12/21 Oppenheimer
Turning Point Therapeutics price target raised to $150 from $130 at Oppenheimer
01/12/21 JMP Securities
Turning Point Therapeutics price target raised to $160 from $125 at JMP Securities
01/12/21 Oppenheimer
Turning Point Therapeutics price target raised to $150 from $130 at Oppenheimer
12/14/20 SVB Leerink
Turning Point Therapeutics price target raised to $127 from $116 at SVB Leerink
TPTX Turning Point Therapeutics
$131.57 /

-6.23 (-4.52%)

  • 27
    Oct
  • 19
    May
Recommendations
IGM Biosciences price target raised to $114 from $88 at H.C. Wainwright » 06:24
01/19/21
01/19
06:24
01/19/21
06:24
IGMS

IGM Biosciences

$97.37 /

+2.365 (+2.49%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGMS IGM Biosciences
$97.37 /

+2.365 (+2.49%)

IGMS IGM Biosciences
$97.37 /

+2.365 (+2.49%)

12/22/20
Fly Intel: Top five analyst downgrades
12/22/20 Wedbush
IGM Biosciences downgraded to Neutral at Wedbush
12/22/20 Wedbush
IGM Biosciences downgraded to Neutral from Outperform at Wedbush
12/06/20 Piper Sandler
IGM Biosciences price target raised to $89 from $81 at Piper Sandler
IGMS IGM Biosciences
$97.37 /

+2.365 (+2.49%)

  • 09
    Dec
IGMS IGM Biosciences
$97.37 /

+2.365 (+2.49%)

IGMS IGM Biosciences
$97.37 /

+2.365 (+2.49%)

Upgrade
Brixmor upgraded to Buy from Neutral at BofA » 06:24
01/19/21
01/19
06:24
01/19/21
06:24
BRX

Brixmor

$16.86 /

-0.025 (-0.15%)

BofA analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRX Brixmor
$16.86 /

-0.025 (-0.15%)

BRX Brixmor
$16.86 /

-0.025 (-0.15%)

06:11 Today BofA
Brixmor upgraded to Buy from Neutral at BofA
12/30/20 Truist
Brixmor price target raised to $17 from $13 at Truist
12/10/20 Wells Fargo
Brixmor downgraded to Equal Weight at Wells Fargo
12/10/20 Wells Fargo
Brixmor downgraded to Equal Weight from Overweight at Wells Fargo
BRX Brixmor
$16.86 /

-0.025 (-0.15%)

Hot Stocks
SPI Energy subsidiary, Icona announce collaboration for all-electric vehicles » 06:24
01/19/21
01/19
06:24
01/19/21
06:24
SPI

SPI Energy

$34.00 /

+12 (+1.00%)

SPI Energy subsidiary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPI SPI Energy
$34.00 /

+12 (+1.00%)

  • 01
    Oct
SPI SPI Energy
$34.00 /

+12 (+1.00%)

SPI SPI Energy
$34.00 /

+12 (+1.00%)

Recommendations
SpringsWorks price target raised to $101 from $87 at H.C. Wainwright » 06:24
01/19/21
01/19
06:24
01/19/21
06:24
SWTX

SpringsWorks Therapeutics

$79.90 /

+5.665 (+7.63%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$79.90 /

+5.665 (+7.63%)

SWTX SpringsWorks Therapeutics
$79.90 /

+5.665 (+7.63%)

12/28/20 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $87 from $73 at H.C. Wainwright
12/17/20 JPMorgan
SpringsWorks Therapeutics price target raised to $85 from $57 at JPMorgan
12/17/20 Barclays
SpringsWorks Therapeutics price target raised to $83 from $70 at Barclays
10/29/20 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $73 from $58 at H.C. Wainwright
SWTX SpringsWorks Therapeutics
$79.90 /

+5.665 (+7.63%)

  • 08
    Oct
Earnings
Citrix sees FY21 adjusted EPS $6.20-$6.40, consensus $6.37 » 06:23
01/19/21
01/19
06:23
01/19/21
06:23
CTXS

Citrix

$132.09 /

+0.07 (+0.05%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTXS Citrix
$132.09 /

+0.07 (+0.05%)

CTXS Citrix
$132.09 /

+0.07 (+0.05%)

10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley
10/23/20 RBC Capital
Citrix price target lowered to $145 from $162 at RBC Capital
10/23/20 Citi
Citrix price target raised to $205 from $195 at Citi
10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight from Overweight at Morgan Stanley
CTXS Citrix
$132.09 /

+0.07 (+0.05%)

CTXS Citrix
$132.09 /

+0.07 (+0.05%)

Recommendations
Xoma price target raised to $56 from $30 at H.C. Wainwright » 06:23
01/19/21
01/19
06:23
01/19/21
06:23
XOMA

Xoma

$39.71 /

+ (+0.00%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOMA Xoma
$39.71 /

+ (+0.00%)

XOMA Xoma
$39.71 /

+ (+0.00%)

03/10/20 H.C. Wainwright
Novartis' recent R&D day driving interest in Xoma, says H.C. Wainwright
XOMA Xoma
$39.71 /

+ (+0.00%)

Downgrade
Pandora A/S downgraded to Hold from Buy at HSBC » 06:23
01/19/21
01/19
06:23
01/19/21
06:23
PANDY

Pandora A/S

$0.00 /

+ (+0.00%)

HSBC analyst Anne-Laure…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PANDY Pandora A/S
$0.00 /

+ (+0.00%)

12/08/20 Danske Bank
Pandora A/S downgraded to Hold from Buy at Danske Bank
11/25/20 BofA
Pandora A/S upgraded to Buy from Neutral at BofA
11/10/20 Morgan Stanley
Pandora A/S price target raised to DKK 560 from DKK 360 at Morgan Stanley
11/04/20 Danske Bank
Pandora A/S upgraded to Buy from Hold at Danske Bank
PANDY Pandora A/S
$0.00 /

+ (+0.00%)

Earnings
Citrix sees Q1 adjusted EPS $1.40-$1.45, consensus $1.47 » 06:22
01/19/21
01/19
06:22
01/19/21
06:22
CTXS

Citrix

$132.09 /

+0.07 (+0.05%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CTXS Citrix
$132.09 /

+0.07 (+0.05%)

CTXS Citrix
$132.09 /

+0.07 (+0.05%)

10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight on slower cloud progress at Morgan Stanley
10/23/20 RBC Capital
Citrix price target lowered to $145 from $162 at RBC Capital
10/23/20 Citi
Citrix price target raised to $205 from $195 at Citi
10/23/20 Morgan Stanley
Citrix downgraded to Equal Weight from Overweight at Morgan Stanley
CTXS Citrix
$132.09 /

+0.07 (+0.05%)

CTXS Citrix
$132.09 /

+0.07 (+0.05%)

Recommendations
Biohaven price target lowered to $111 from $121 at H.C. Wainwright » 06:22
01/19/21
01/19
06:22
01/19/21
06:22
BHVN

Biohaven Pharmaceutical

$84.76 /

-7.065 (-7.69%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

04:54 Today Piper Sandler
Biohaven should pull back to mid-$70's on Alzheimer's miss, says Piper Sandler
12/29/20 Cantor Fitzgerald
Biohaven price target raised to $115 from $109 at Cantor Fitzgerald
12/23/20 Piper Sandler
Piper 'comfortable' owning Biohaven shares into Alzheimer's readout
12/15/20 H.C. Wainwright
Biohaven Pharmaceutical initiated with a Buy at H.C. Wainwright
BHVN Biohaven Pharmaceutical
$84.76 /

-7.065 (-7.69%)

  • 29
    Jan
Initiation
Airbnb initiated with a Sell at Redburn » 06:22
01/19/21
01/19
06:22
01/19/21
06:22
ABNB

ABNB

/

+

Redburn initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABNB ABNB
/

+

ABNB ABNB
/

+

01/14/21 Truist
Airbnb initiated with a Hold at Truist
01/08/21 Tigress Financial
Airbnb initiated with a Buy at Tigress Financial
01/05/21 William Blair
Blair starts Airbnb with Outperform on 'strong' consumer awareness
01/05/21 Citi
Airbnb initiated with a Neutral at Citi
  • 10
    Dec
ABNB ABNB
/

+

ABNB ABNB
/

+

ABNB ABNB
/

+

Upgrade
WWE upgraded to Outperform from In Line at Evercore ISI » 06:21
01/19/21
01/19
06:21
01/19/21
06:21
WWE

WWE

$37.00 /

+12 (+5.00%)

Evercore ISI analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WWE WWE
$37.00 /

+12 (+5.00%)

WWE WWE
$37.00 /

+12 (+5.00%)

01/11/21
Fly Intel: Top five analyst initiations
01/11/21 Barclays
WWE initiated with an Equal Weight at Barclays
10/27/20 Morgan Stanley
WWE price target lowered to $47 from $52 at Morgan Stanley
10/06/20 MKM Partners
WWE price target lowered to $50 from $58 at MKM Partners
WWE WWE
$37.00 /

+12 (+5.00%)

  • 25
    Mar
WWE WWE
$37.00 /

+12 (+5.00%)

WWE WWE
$37.00 /

+12 (+5.00%)

Upgrade
WWE upgraded to Outperform from In Line at Evercore ISI » 06:21
01/19/21
01/19
06:21
01/19/21
06:21
WWE

WWE

$50.86 /

-0.89 (-1.72%)

Evercore ISI analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WWE WWE
$50.86 /

-0.89 (-1.72%)

WWE WWE
$50.86 /

-0.89 (-1.72%)

01/11/21
Fly Intel: Top five analyst initiations
01/11/21 Barclays
WWE initiated with an Equal Weight at Barclays
10/27/20 Morgan Stanley
WWE price target lowered to $47 from $52 at Morgan Stanley
10/06/20 MKM Partners
WWE price target lowered to $50 from $58 at MKM Partners
WWE WWE
$50.86 /

-0.89 (-1.72%)

  • 25
    Mar
WWE WWE
$50.86 /

-0.89 (-1.72%)

WWE WWE
$50.86 /

-0.89 (-1.72%)

Downgrade
Live Nation downgraded to In Line from Outperform at Evercore ISI » 06:21
01/19/21
01/19
06:21
01/19/21
06:21
LYV

Live Nation

$71.52 /

-1.83 (-2.49%)

Evercore ISI analyst Josh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYV Live Nation
$71.52 /

-1.83 (-2.49%)

LYV Live Nation
$71.52 /

-1.83 (-2.49%)

12/17/20 Morgan Stanley
Live Nation price target raised to $70 from $56 at Morgan Stanley
11/30/20 Macquarie
Live Nation downgraded to Neutral on valuation at Macquarie
11/30/20 Macquarie
Live Nation downgraded to Neutral from Outperform at Macquarie
10/27/20 Jefferies
Live Nation downgraded to Hold from Buy at Jefferies
LYV Live Nation
$71.52 /

-1.83 (-2.49%)

LYV Live Nation
$71.52 /

-1.83 (-2.49%)

LYV Live Nation
$71.52 /

-1.83 (-2.49%)

LYV Live Nation
$71.52 /

-1.83 (-2.49%)

Upgrade
Retail Opportunity double-upgraded to Buy from Underperform at BofA » 06:21
01/19/21
01/19
06:21
01/19/21
06:21
ROIC

Retail Opportunity

$14.31 /

-0.085 (-0.59%)

BofA analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROIC Retail Opportunity
$14.31 /

-0.085 (-0.59%)

06:11 Today BofA
Retail Opportunity upgraded to Buy from Underperform at BofA
12/14/20 KeyBanc
Retail Opportunity downgraded to Sector Weight from Overweight at KeyBanc
12/10/20 Wells Fargo
Retail Opportunity downgraded to Underweight at Wells Fargo
12/10/20 Wells Fargo
Retail Opportunity downgraded to Underweight from Equal Weight at Wells Fargo
ROIC Retail Opportunity
$14.31 /

-0.085 (-0.59%)

Recommendations
Acceleron price target raised to $168 from $148 at H.C. Wainwright » 06:21
01/19/21
01/19
06:21
01/19/21
06:21
XLRN

Acceleron

$126.32 /

-0.7 (-0.55%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$126.32 /

-0.7 (-0.55%)

XLRN Acceleron
$126.32 /

-0.7 (-0.55%)

12/21/20 Barclays
Acceleron price target raised to $150 from $133 at Barclays
11/16/20 Oppenheimer
Acceleron price target raised to $131 from $120 at Oppenheimer
11/06/20 H.C. Wainwright
Acceleron price target raised to $148 from $137 at H.C. Wainwright
10/02/20 Piper Sandler
Piper says Acceleron STELLAR trial design details generally as expected
XLRN Acceleron
$126.32 /

-0.7 (-0.55%)

  • 01
    Jul
Recommendations
TG Therapeutics price target raised to $78 from $61 at H.C. Wainwright » 06:19
01/19/21
01/19
06:19
01/19/21
06:19
TGTX

TG Therapeutics

$49.56 /

-1.64 (-3.20%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$49.56 /

-1.64 (-3.20%)

TGTX TG Therapeutics
$49.56 /

-1.64 (-3.20%)

12/10/20 H.C. Wainwright
TG Therapeutics price target raised to $61 from $38 at H.C. Wainwright
12/10/20 Evercore ISI
TG Therapeutics price target raised to $70 from $65 at Evercore ISI
10/28/20 Cantor Fitzgerald
TG Therapeutics price target raised to $48 from $30 at Cantor Fitzgerald
10/09/20 B. Riley Securities
TG Therapeutics price target raised to $52 from $37 at B. Riley Securities
TGTX TG Therapeutics
$49.56 /

-1.64 (-3.20%)

  • 15
    Dec
  • 15
    May
TGTX TG Therapeutics
$49.56 /

-1.64 (-3.20%)

TGTX TG Therapeutics
$49.56 /

-1.64 (-3.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.